Different Injection Site Maps & Intravesical Botulinum Toxin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-31

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Botulinum toxin injection into the bladder is used in current practice in urological diseases such as overactive bladder or interstitial cystitis. As far as is known, botulinum toxin injection sites have not been clearly defined. In this study, investigators are planning to compare botulinum toxin effectiveness with different injection site maps.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Trigonal vs Non Trigonal Botox Injection in OAB.

NCT03533062

Urologic Diseases Overactive Bladder Syndrome Quality of Life +1 more

COMPLETED NA

Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients

NCT01997983

Interstitial Cystitis IC

COMPLETED PHASE1/PHASE2

The Efficacy of Botulinum Toxin in OVERACTIVE Bladder

NCT03888001

Overactive Bladder

UNKNOWN

A Research Study for Patients With Overactive Bladder

NCT00168454

Overactive Bladder Urinary Incontinence

COMPLETED PHASE2

Intravesicular Onabotulinumtoxin A in Interstitial Cystitis

NCT02297100

Interstitial Cystitis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bladder Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAP 1 (Posterior wall only)

Type 1 map injection will be used to bladder in one session. In this arm, Botulinum toxin type A injection will be apply to non-trigonal only posterior wall of bladder. The application will be done with cystoscopy and, 20 different point will be aimed. Totally 100 IU Botulinum toxin type A will be applied.

Group Type ACTIVE_COMPARATOR

Intravesical Botulinum Toxin

Intervention Type OTHER

Botulinum Toxin injections will be made into the bladder.

MAP 2 (Posterior wall + bilateral side walls)

Type 2 map injection will be used to bladder in one session. In this arm, Botulinum toxin type A injection will be apply to non-trigonal posterior wall + bilateral side walls of bladder. The application will be done with cystoscopy and, 20 different point will be aimed. Totally 100 IU Botulinum toxin type A will be applied.

Group Type ACTIVE_COMPARATOR

Intravesical Botulinum Toxin

Intervention Type OTHER

Botulinum Toxin injections will be made into the bladder.

MAP 3 (Non-trigonal all walls)

Type 3 map injection will be used to bladder in one session In this arm, Botulinum toxin type A injection will be apply to non-trigonal all walls of bladder. The application will be done with cystoscopy and, 20 different point will be aimed. Totally 100 IU Botulinum toxin type A will be applied.

Group Type ACTIVE_COMPARATOR